Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128647) titled 'A Clinical Study of 68Ga-GPC3-XT Injection PET Imaging for the Diagnosis of Hepatocellular Carcinoma (HCC) Patients' on July 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Chinese People's Liberation Army (PLA) General Hospital
Condition:
Hepatocellular Carcinoma
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-02
Target Sample Size: Experimental group:12;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=330727
Disclaimer: Curated by HT Syndication....